Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.
An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.
Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.
This chapter was published in IP in the Life Sciences.
To continue reading, please contact us at firstname.lastname@example.org